Combining with the findings of this meta-analysis that PDGFR-β+-CAFs is significantly correlated with poor differentiation and poor prognosis of breast cancer, targeting PDGFR pathways may be a potentially effective tumor treatment strategy. This evidence concerns the gene PDGFRB and breast carcinoma.